SUMMARY
Clinical tools to identify individuals with unstable atherosclerotic lesions are required to improve prevention of myocardial infarction and ischemic stroke. Here, a systems-based analysis of atherosclerotic plaques and plasma from patients undergoing carotid endarterectomy for stroke prevention was used to identify molecular signatures with a causal relationship to disease. Local plasma collected in the lesion proximity following clamping prior to arteriotomy was profiled together with matched peripheral plasma. This translational workflow identified biliverdin reductase B as a novel marker of intraplaque hemorrhage and unstable carotid atherosclerosis, which should be investigated as a potential predictive biomarker for cardiovascular events in Here, we developed a novel pipeline for identi- Supernatants were transferred to cryotubes and stored at À80 C until analyzed. The surgical procedure was continued with arteriotomy and CEA, and the plaque was retrieved for analysis as previously described (14, 15, 17 
LC-MS/MS PROTEOMICS SAMPLE PREPARATION.
CEA tissue specimens from 18 patients matched for male sex, age, and statin medication were analyzed using LC-MS/MS as previously described (20, 21) . Table 1 and were also described in detail previously (11, 18) . Matic et al.
A
significantly altered expression in plaque microarrays, 13 had altered plaque protein levels and the majority of these candidates were up-regulated (Supplemental Table 3 ). BLVRB was confirmed as being among the most significant candidates in these analyses and the only one enriched also in local plasma; thus, it was selected for further validation studies. Figure 3A) and by sandwich immunoassay in both discovery and validation plasma samples ( Figure 2F ).
BLVRB IS ENRICHED IN PLAQUES
Immunocapture-mass spectrometry verified that Matic et al. Figure 3A) and by quantitative polymerase chain reaction from 2 validation sets of patients. BLVRB protein levels were also significantly higher in plaques from symptomatic patients by LC-MS/MS ( Figure 3B ). The same trend was observed in local plasma assayed with antibody bead arrays for both BLVRB antibodies ( Figure 3C) and in sandwich immunoassay (Supplemental Figure 3B ).
BLVRB LOCALIZES TO CD68D CELLS IN PLAQUES.
To understand which cell types in plaques express BLVRB, we next correlated BLVRB messenger Figure 4D ).
BLVRB MAY BE ASSOCIATED WITH HEME-METABOLISM VIA HMOX1 IN REGIONS OF INTRAPLAQUE HEMORRHAGE.
Whereas the role of BLVRA in Hb metabolism via heme oxygenase (HMOX) has been well described (28) , less is known about the implication of BLVRB in the same process, and so far there are no 
Stratification of patients based on clinical symptoms of atherosclerosis showed that BLVRB mRNA (A) and protein (B) expression was induced in comparison between symptomatic (S) and asymptomatic (AS) patients in plaques by microarrays, qPCR, and LC-MS/MS, as well as in local
plasma by antibody bead arrays using both human protein atlas antibodies targeting BLVRB (HPA041937 and HPA041698) (C). Abbreviations as in Figures 1 and 2 .
FIGURE 4 BLVRB Localizes to CD68þ Cells in Plaques
In plaque transcriptomic (A) and proteomic (B) datasets, BLVRB showed strong significant correlations to markers of macrophages (CD163, CD36). By double immunohistochemistry, BLVRB (red signal) localized primarily to CD68þ cells in the necrotic core of plaques (green signal, enlarged insets). No signal was observed in adventitia of normal arteries (C). By single immunohistochemistry, BLVRB was also detected in necrotic core regions positive for CD163 (D). neg ¼ negative; other abbreviations as in Figures 1 and 2 .
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FIGURE 5 BLVRB May Be Associated With Heme-Catabolism in Plaques via HMOX1
Heme oxygenase 1 (HMOX1) mRNA was highly up-regulated in Biobank of Karolinska Endarterectomies microarrays comparing plaques and normal arteries and strongly correlated to that of BLVRB. Plots showing log 2 mean AE SD and Spearman correlation (A). Induction of HMOX1
and correlation with BLVRB could be verified on the protein level by LC-MS/MS from plaques compared with adjacent tissue (B). No staining for HMOX1 was observed in the normal carotid artery, whereas weak signal for BLVRB could occasionally be seen in adventitia. Using consecutive sections of plaques, HMOX1 was localized to the sites of hemorrhage with infiltrated erythrocytes, where it overlapped with BLVRB and Perls blue staining for iron deposits (C, enlarged insets). The correlation between BLVRB and HMOX1 content and intraplaque hemorrhage was also assessed quantitatively, using histological staining on TMA constructed from 106 plaques (D, plot to the right).
Abbreviations as in Figures 1 to 3 .
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BLVRB AND HMOX1 LEVELS CORRELATE WITH ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS.
With respect to clinical importance, significant enrichment of BLVRB could be confirmed also in peripheral plasma from patients with carotid atherosclerosis versus healthy control subjects, both in the discovery and in the validation set of samples from BiKE ( Figure 8A) . Furthermore, elevated BLVRB levels could be detected with 2 antibodies in an independent population cohort where individuals were Matic et al.
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A U G U S T 2 0 1 8 : 4 6 4 -8 0 stratified by CAC score as a surrogate marker of coronary artery disease (1,033 individuals in total) ( Figure 8B ). In association with clinical parameters, we also found that BLVRB and HMOX1 expression were increased in plaques from patients with history of myocardial infarction ( Figure 8C ), and patients with above-median plaque expression levels of HMOX1 had a higher risk of future adverse cardiovascular and cerebrovascular events ( Figure 8D) . A similar trend was noted for BLVRB, although it did not reach statistical significance (Supplemental Figure 7) . Last, expression of BLVRB and HMOX1 in plaques was positively correlated to carotid plaque echolucency as evaluated by pre-operative ultrasound ( Figure 8E ).
DISCUSSION
Here, we integrated data from 3 different omicstechnology platforms for unbiased discovery of molecular signatures in carotid atherosclerosis, with potential for future biomarker development to identify individuals who are at high risk of stroke.
We applied a novel translational workflow, where differentially regulated candidates were interrogated in transcriptomic and proteomic profiles of plaques and plasma from patients undergoing carotid surgery to discover circulating proteins likely originating from unstable lesions and, thus, with a causal relationship to the disease. The results were validated in independent cohorts and normal catalyze the same reaction, they may have different functions. HMOX2 is the constitutive form, whereas HMOX1 is the stress responsive cognate, which is normally expressed at low levels and induced in atherosclerosis by free radicals and hypoxia (37) . The levels of HMOX1 were found to be the highest in patients with previous myocardial infarction, but it is unclear whether this represents a protective mechanism or a pathophysiological consequence of the disease (38) . BLVR is another major enzyme of heme catabolism in macrophages, Matic et al.
A U G U S T 2 0 1 8 : 4 6 4 -8 0 resulting in the degradation products carbon monoxide, ferrous iron, and biliverdin (28) . BLVR occurs in the form of 2 isozymes (BLVRA and BLVRB), which have redundant as well as distinct functions and differ in their reduction specificity (27) . BLVRB is expressed in the early fetal stages, whereas BLVRA expression increases later in gestation (39) and remains ubiquitously expressed in adults (40) . In the context of atherosclerosis, this study is to our knowledge the first report of a role for BVLRB. where plasma levels of BLVRB will be correlated to the presence of intraplaque hemorrhage by carotid cardiac magnetic resonance imaging. In addition, populationbased longitudinal studies will be performed to address the value of BLVRB in risk prediction of myocardial infarction and ischemic stroke.
